The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans

Qiao Yi Chen, David Nadell, Xian Yang Zhang, Anjli Kukreja, Yao Jin Huang, Jonathan Wise, Frank Svec, Robert Richards, Karen E. Friday, Alfonso Vargas, Ricardo Gomez, Stuart Chalew, Michael S. Lan, Yaron Tomer, Noel K. Maclaren

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Information on genetic susceptibility to Graves' disease in African Americans is limited. We studied DRB1, DQB1, DRB3 subtypes, DQA1*0501, DQA1*0201, and CTLA-4 polymorphisms in 49 African American patients with adult onset Graves' disease and 47 racially-matched controls using PCR-based sequence-specific priming methods. There were no significant differences in DRB1 or DQB1 allelic frequencies or CTLA-4 polymorphisms between patients and controls. However, we found that the frequency of DRB3 was significantly increased in the patients (75.5% vs. 57.4%, P = 0.006, X2 = 3.52), especially for the DRB3*0202 subtype (53.1% vs. 23.4, P = 0.003, X2 = 8.91). In this one respect, the finding was in concordance with our previous observations in Caucasian patients with adult-onset Graves' disease. In addition, whereas the frequency of DQA1*0501 was increased (P = 0.018, X2 = 5.63) in our patients, the haplotype of DRB3/DQA1*0501, or DRB3*0202/DQA1*0501 was found to be more strongly associated (P = 0.008, X2 = 7.0; P = 0.0008, X2 = 11.34, respectively). These data suggest that DRB3*0202, particularly when found with DQA1*0501 in a haplotype is a susceptible gene(s) for Graves' disease in adult African Americans. Considering these data with those in Caucasian patients, our results would suggest that the primary Graves susceptible locus is likely DRB3 and not DRB1.

Original languageEnglish (US)
Pages (from-to)1545-1549
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number4
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

HLA-DRB3 Chains
Graves Disease
HLA Antigens
African Americans
Haplotypes
Polymorphism
Genes
Genetic Predisposition to Disease
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans. / Chen, Qiao Yi; Nadell, David; Zhang, Xian Yang; Kukreja, Anjli; Huang, Yao Jin; Wise, Jonathan; Svec, Frank; Richards, Robert; Friday, Karen E.; Vargas, Alfonso; Gomez, Ricardo; Chalew, Stuart; Lan, Michael S.; Tomer, Yaron; Maclaren, Noel K.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 4, 2000, p. 1545-1549.

Research output: Contribution to journalArticle

Chen, QY, Nadell, D, Zhang, XY, Kukreja, A, Huang, YJ, Wise, J, Svec, F, Richards, R, Friday, KE, Vargas, A, Gomez, R, Chalew, S, Lan, MS, Tomer, Y & Maclaren, NK 2000, 'The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans', Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1545-1549. https://doi.org/10.1210/jc.85.4.1545
Chen, Qiao Yi ; Nadell, David ; Zhang, Xian Yang ; Kukreja, Anjli ; Huang, Yao Jin ; Wise, Jonathan ; Svec, Frank ; Richards, Robert ; Friday, Karen E. ; Vargas, Alfonso ; Gomez, Ricardo ; Chalew, Stuart ; Lan, Michael S. ; Tomer, Yaron ; Maclaren, Noel K. / The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 4. pp. 1545-1549.
@article{7ae92d5eb2d94b5dae57cf499fb01a95,
title = "The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans",
abstract = "Information on genetic susceptibility to Graves' disease in African Americans is limited. We studied DRB1, DQB1, DRB3 subtypes, DQA1*0501, DQA1*0201, and CTLA-4 polymorphisms in 49 African American patients with adult onset Graves' disease and 47 racially-matched controls using PCR-based sequence-specific priming methods. There were no significant differences in DRB1 or DQB1 allelic frequencies or CTLA-4 polymorphisms between patients and controls. However, we found that the frequency of DRB3 was significantly increased in the patients (75.5{\%} vs. 57.4{\%}, P = 0.006, X2 = 3.52), especially for the DRB3*0202 subtype (53.1{\%} vs. 23.4, P = 0.003, X2 = 8.91). In this one respect, the finding was in concordance with our previous observations in Caucasian patients with adult-onset Graves' disease. In addition, whereas the frequency of DQA1*0501 was increased (P = 0.018, X2 = 5.63) in our patients, the haplotype of DRB3/DQA1*0501, or DRB3*0202/DQA1*0501 was found to be more strongly associated (P = 0.008, X2 = 7.0; P = 0.0008, X2 = 11.34, respectively). These data suggest that DRB3*0202, particularly when found with DQA1*0501 in a haplotype is a susceptible gene(s) for Graves' disease in adult African Americans. Considering these data with those in Caucasian patients, our results would suggest that the primary Graves susceptible locus is likely DRB3 and not DRB1.",
author = "Chen, {Qiao Yi} and David Nadell and Zhang, {Xian Yang} and Anjli Kukreja and Huang, {Yao Jin} and Jonathan Wise and Frank Svec and Robert Richards and Friday, {Karen E.} and Alfonso Vargas and Ricardo Gomez and Stuart Chalew and Lan, {Michael S.} and Yaron Tomer and Maclaren, {Noel K.}",
year = "2000",
doi = "10.1210/jc.85.4.1545",
language = "English (US)",
volume = "85",
pages = "1545--1549",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - The human leukocyte antigen HLA DRB3*0202/DQA1*0501 haplotype is associated with Graves' disease in African Americans

AU - Chen, Qiao Yi

AU - Nadell, David

AU - Zhang, Xian Yang

AU - Kukreja, Anjli

AU - Huang, Yao Jin

AU - Wise, Jonathan

AU - Svec, Frank

AU - Richards, Robert

AU - Friday, Karen E.

AU - Vargas, Alfonso

AU - Gomez, Ricardo

AU - Chalew, Stuart

AU - Lan, Michael S.

AU - Tomer, Yaron

AU - Maclaren, Noel K.

PY - 2000

Y1 - 2000

N2 - Information on genetic susceptibility to Graves' disease in African Americans is limited. We studied DRB1, DQB1, DRB3 subtypes, DQA1*0501, DQA1*0201, and CTLA-4 polymorphisms in 49 African American patients with adult onset Graves' disease and 47 racially-matched controls using PCR-based sequence-specific priming methods. There were no significant differences in DRB1 or DQB1 allelic frequencies or CTLA-4 polymorphisms between patients and controls. However, we found that the frequency of DRB3 was significantly increased in the patients (75.5% vs. 57.4%, P = 0.006, X2 = 3.52), especially for the DRB3*0202 subtype (53.1% vs. 23.4, P = 0.003, X2 = 8.91). In this one respect, the finding was in concordance with our previous observations in Caucasian patients with adult-onset Graves' disease. In addition, whereas the frequency of DQA1*0501 was increased (P = 0.018, X2 = 5.63) in our patients, the haplotype of DRB3/DQA1*0501, or DRB3*0202/DQA1*0501 was found to be more strongly associated (P = 0.008, X2 = 7.0; P = 0.0008, X2 = 11.34, respectively). These data suggest that DRB3*0202, particularly when found with DQA1*0501 in a haplotype is a susceptible gene(s) for Graves' disease in adult African Americans. Considering these data with those in Caucasian patients, our results would suggest that the primary Graves susceptible locus is likely DRB3 and not DRB1.

AB - Information on genetic susceptibility to Graves' disease in African Americans is limited. We studied DRB1, DQB1, DRB3 subtypes, DQA1*0501, DQA1*0201, and CTLA-4 polymorphisms in 49 African American patients with adult onset Graves' disease and 47 racially-matched controls using PCR-based sequence-specific priming methods. There were no significant differences in DRB1 or DQB1 allelic frequencies or CTLA-4 polymorphisms between patients and controls. However, we found that the frequency of DRB3 was significantly increased in the patients (75.5% vs. 57.4%, P = 0.006, X2 = 3.52), especially for the DRB3*0202 subtype (53.1% vs. 23.4, P = 0.003, X2 = 8.91). In this one respect, the finding was in concordance with our previous observations in Caucasian patients with adult-onset Graves' disease. In addition, whereas the frequency of DQA1*0501 was increased (P = 0.018, X2 = 5.63) in our patients, the haplotype of DRB3/DQA1*0501, or DRB3*0202/DQA1*0501 was found to be more strongly associated (P = 0.008, X2 = 7.0; P = 0.0008, X2 = 11.34, respectively). These data suggest that DRB3*0202, particularly when found with DQA1*0501 in a haplotype is a susceptible gene(s) for Graves' disease in adult African Americans. Considering these data with those in Caucasian patients, our results would suggest that the primary Graves susceptible locus is likely DRB3 and not DRB1.

UR - http://www.scopus.com/inward/record.url?scp=17744366587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744366587&partnerID=8YFLogxK

U2 - 10.1210/jc.85.4.1545

DO - 10.1210/jc.85.4.1545

M3 - Article

C2 - 10770195

AN - SCOPUS:17744366587

VL - 85

SP - 1545

EP - 1549

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -